The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Blog
Melony G. Griffith President & CEO Maryland Hospital AssociationGrowing up in Great Falls, Mont., raised by two military veterans and public…
Headline
More than 230 nurse leaders from 37 states attended the American Organization for Nursing Leadership Advocacy Academy and its Advocacy Day June 2-4 in…
Blog
The American Hospital Association Leadership Summit will take place July 21-23, 2024, in San Diego, Calif., at the Manchester Grand Hyatt. Renowned speakers…
Headline
Jim Tinker, 81, former president and CEO of Mercy Medical Center in Cedar Rapids, Iowa, died April 21. Tinker served in this role from 1982 to 2006. During his…
Headline
Herbert Pardes, M.D., 89, former president and CEO of NewYork-Presbyterian, died this week following an illness. Pardes was a longstanding and influential…
Headline
Nurse managers who interact purposefully with each registered nurse on their team have lower turnover, with monthly interactions such as recognitions, check-…